---
layout: post
title: What's new for 'angiotensin AND cancer' in PubMed - coffee, statins, ACE inhibitors
  and more!
date: '2011-10-15T11:15:00.002-03:00'
author: Francisco H C Felix
tags:
- Cancer
lang: en
ref:
modified_time: '2011-10-15T11:43:20.068-03:00'
blogger_id: tag:blogger.com,1999:blog-2993346515708552092.post-2656953664171655646
blogger_orig_url: https://pharmak.blogspot.com/2011/10/whats-new-for-angiotensin-and-cancer-in.html
---

This message contains My NCBI what's new results from the National Center for Biotechnology<br /><b>Sender's message: </b> <br />Sent on Saturday, 2011 Oct 08<br />Search <b>angiotensin cancer</b> <br /><div><br /><div><table bgcolor="#CCCCCC"><tbody><tr><td align="center">PubMed Results</td></tr></tbody></table>Items 1 - 4</div><br /><div><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">1.</td><td valign="top"><a href="https://www.ncbi.nlm.nih.gov/pubmed/21970881" ref="ordinalpos=1">Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Tanaka N,  Miyajima A,  Kosaka T,  Miyazaki Y,  Shirotake S,  Shirakawa H,  Kikuchi E,  Oya M.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="British journal of cancer">Br J Cancer</span>. 2011 Oct 4. doi: 10.1038/bjc.2011.399. [Epub ahead of print]</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21970881 [PubMed - as supplied by publisher]<br /><br /><b>How angiotensin II type 1 receptor blockers can overcome platinum resistance in cancer cells.</b></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">2.</td><td valign="top"><a href="https://www.ncbi.nlm.nih.gov/pubmed/21813413" ref="ordinalpos=2">Statin prescriptions and breast cancer recurrence risk: a danish nationwide prospective cohort study.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Ahern TP,  Pedersen L,  Tarp M,  Cronin-Fenton DP,  Garne JP,  Silliman RA,  SÃ¸rensen HT,  Lash TL.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="Journal of the National Cancer Institute">J Natl Cancer Inst</span>. 2011 Oct 5;103(19):1461-8. Epub 2011 Aug 2.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21813413 [PubMed - in process]<br /><br /><b>Simvastatin users had less breast cancer recurrence - a Harvard Medical School Study</b></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">3.</td><td valign="top"><a href="https://www.ncbi.nlm.nih.gov/pubmed/21876027" ref="ordinalpos=3">Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Yoon C,  Yang HS,  Jeon I,  Chang Y,  Park SM.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne">CMAJ</span>. 2011 Oct 4;183(14):E1073-84. Epub 2011 Aug 29.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21876027 [PubMed - in process]<span style="color: #985735; font-weight: bold;">   Free Article&nbsp;</span><br /><br /><span style="color: #985735; font-weight: bold;">Last word on ACE inhibitors/AT1R blockers and cancer: they can be protective, after all! </span></td></tr></tbody></table><table cellpadding="0" cellspacing="5"><tbody><tr><td nowrap="nowrap" valign="top" width="10">4.</td><td valign="top"><a href="https://www.ncbi.nlm.nih.gov/pubmed/21961901" ref="ordinalpos=4">High Molecular Weight Coffee Melanoidins are Inhibitors for Matrix Metalloproteases.</a></td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">Demarco LM,  Fischer S,  Henle T.</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top"><span class="jrnl" title="Journal of agricultural and food chemistry">J Agric Food Chem</span>. 2011 Oct 1. [Epub ahead of print]</td></tr><tr><td align="left" valign="top" width="10"><br /></td><td align="left" valign="top">PMID: 21961901 [PubMed - as supplied by publisher]<br /><br /><b>Coffee, sir?&nbsp; Melanoidins from coffee - a new group of MMP inhibitors that can play a pivotal role in cancer treatment.</b></td></tr></tbody></table></div></div>
